Gene Park

Title: Gene Park: Innovator in Vascular Treatment Technologies

Introduction

Gene Park is a notable inventor based in Oakland, CA (US), recognized for his contributions to the field of vascular treatment technologies. With a total of 6 patents to his name, Park has made significant strides in developing innovative solutions for vascular disorders.

Latest Patents

Among his latest patents, Park has developed an anti-proliferative and anti-inflammatory agent combination for the treatment of vascular disorders. This includes drug-delivery systems such as drug-delivery stents that incorporate an anti-proliferative agent like everolimus and an anti-inflammatory agent such as clobetasol. These inventions also detail methods for treating vascular impairments, including restenosis or vulnerable plaque. Another notable patent involves a drug-delivery system that contains at least 100 µg of everolimus and clobetasol, ensuring that the ratio of everolimus to clobetasol is at least 10:1 (w/w). This system can be utilized in stents and provides a method for treating vascular issues by locally administering these drugs to patients.

Career Highlights

Gene Park has had a distinguished career, working with prominent companies such as The Clorox Company and Abbott Cardiovascular Systems, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Throughout his career, Park has collaborated with notable professionals, including James E. Rader and Scott T. Haubrich. These collaborations have further enhanced his work in the field of vascular treatment.

Conclusion

Gene Park's innovative contributions to vascular treatment technologies highlight his role as a leading inventor in the medical field. His patents reflect a commitment to improving patient outcomes through advanced drug-delivery systems.